Índice Bovespa

US Dollar vs BRL

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
BioNexus Gene Lab Corporation (PK) (BGLC)
BioNexus Gene Lab Corporation (PK) (BGLC) Notícias

BGLC

BioNexus Gene Lab (PK) (BGLC)

BioNexus Gene Lab Corporation (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:BGLC

1

Data	Hora	Fonte	Título	Código	Companhia
15/05/2024	14:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
18/04/2024	14:44	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
16/04/2024	14:00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
28/03/2024	16:59	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
26/03/2024	16:59	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
29/02/2024	19:16	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
14/11/2023	13:54	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
30/10/2023	13:14	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
17/10/2023	12:46	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
04/10/2023	16:57	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
21/07/2023	16:37	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
20/07/2023	13:28	Edgar (US Regulatory)	Form CERT - Certification by an exchange approving securities for listing	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
20/07/2023	01:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
19/07/2023	15:35	Edgar (US Regulatory)	Form 8-A12B - Registration of securities [Section 12(b)]	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
17/05/2023	10:07	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
09/05/2023	12:40	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
31/03/2023	10:58	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
10/03/2023	12:35	Edgar (US Regulatory)	Information Statement (definitive, Revised) (defr14c)	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
14/02/2023	16:38	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
15/08/2022	16:36	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
01/04/2022	18:19	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)
09/11/2020	11:13	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:BGLC	BioNexus Gene Lab Corporation (PK)

Apresentando as notícias mais relevantes sobre:USOTC:BGLC

1

Credit Suisse AG Nassau ... (PK)

PETRG230 Ex:20,12

21SHARES ASND INAV

Nationale Nederlanden Ba...

SSgA SPDR ETFs EUROPE I ...

Pear Therapeutics

ISHARES IUME INAV

VanEck Durable High Divi...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições